Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Washington Court Hotel

25 sep 2013 8:00 a.m. - 27 sep 2013 5:00 p.m.

525 New Jersey Avenue NW, Washington, DC 20001

DIA/FDA Oligonucleotide-based Therapeutics Conference

Session Chair(s)

René  Thürmer, PHD

René Thürmer, PHD

Quality Assessor

Federal Institute for Drugs and Medical Devices, Germany

Speaker(s)

Jeremy  Heidel, PHD

Complex Polymeric Formulations of Oligonucleotides

Jeremy Heidel, PHD

Informulate LLC, United States

President

Bob D. Brown, PHD

Solid Lipid Nanoparticle Formulations of Oligonucleotides

Bob D. Brown, PHD

Dicerna Pharmaceuticals, United States

Chief Scientific Officer

Robert T. Dorsam, PHD

Panelist

Robert T. Dorsam, PHD

FDA, United States

Associate Director, Pharmacology/Toxicology, Office of Generic Drugs, CDER

Jeremy  Heidel, PHD

Panelist

Jeremy Heidel, PHD

Informulate LLC, United States

President

Bob D. Brown, PHD

Panelist

Bob D. Brown, PHD

Dicerna Pharmaceuticals, United States

Chief Scientific Officer

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.